Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1595
Full Text
Open PDFAbstract
Available in full text
Date
September 7, 2011
Authors
Publisher
American Association for Cancer Research (AACR)